Plasma markers of endothelial dysfunction in type 2 diabetics
- 31 January 2006
- journal article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 17 (1) , 38-42
- https://doi.org/10.1016/j.ejim.2005.09.015
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A within the normal rangeEuropean Heart Journal, 2004
- Reduced PAF-acetylhydrolase activity associated with Lp(a) in patients with coronary artery diseaseAtherosclerosis, 2004
- Oxidation of low density lipoproteins by myeloperoxidase at the surface of endothelial cells: an additional mechanism to subendothelium oxidationBiochemical and Biophysical Research Communications, 2004
- The significance of human platelet-activating factor-acetylhydrolase in patients with chronic stable anginaEuropean Journal of Internal Medicine, 2004
- Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cellsBiochemical and Biophysical Research Communications, 2004
- Diabetes and atherogenesisHeart, 2004
- Hypochlorous Acid Generated by Myeloperoxidase Modifies Adjacent Tryptophan and Glycine Residues in the Catalytic Domain of Matrix Metalloproteinase-7 (Matrilysin)Journal of Biological Chemistry, 2003
- Prognostic implications of endothelial dysfunction: does it mean anything?Coronary Artery Disease, 2001
- Nonenzymatic glycosylation of HDL and impaired HDL-receptor-mediated cholesterol effluxDiabetes, 1991
- Diabetes and cardiovascular disease. The Framingham studyJAMA, 1979